← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2018Last known activity
Jul 15, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 8 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (19)
- NCT06404177Sponsor investigatorPhase 3Jul 15, 2023
- NCT06404177Lead sponsorPhase 3Jul 15, 2023
- NCT05670444Lead sponsorPhase 1Jan 2, 2023
- NCT05670444Reponsible party - principal investigatorPhase 1Jan 2, 2023
- NCT04989101Reponsible party - principal investigatorN/AJun 5, 2021
- NCT04989101Overall official - principal investigatorN/AJun 5, 2021
- NCT04989101Lead sponsorN/AJun 5, 2021
- NCT04853199Lead sponsorEarly Phase 1Jun 1, 2021
- NCT04853199Overall official - principal investigatorEarly Phase 1Jun 1, 2021
- NCT04914767Reponsible party - principal investigatorPhase 1Mar 1, 2021
- NCT04914767Overall official - principal investigatorPhase 1Mar 1, 2021
- NCT04914767Lead sponsorPhase 1Mar 1, 2021
- NCT04851821Lead sponsorPhase 1Jan 4, 2021
- NCT04851821Overall official - principal investigatorPhase 1Jan 4, 2021
- NCT04978025Lead sponsorN/ANov 1, 2020
Details
- Last known activity
- Jul 15, 2023